Clinical trials: Psychomotor Performance
- Condition Psychomotor Performance
- Funder type Industry (pharma, biotech, devices)
- Has posted results yes
Overweight, Obesity
A Study to Evaluate How VI-0521 Affect Psychomotor Performance in Healthy Overweight and Obese Subjects.
The purpose of this study is to determine how VI-0521 affect speed and reaction time on specific tasks that require eye and hand coordination, compared to placebo.
- Trial name
- NCT00806260
- Testing
- VI-0521, Alcohol
- Where
- United States
- Volunteers
- 80 people, healthy volunteers welcome
- Sponsor
- VIVUS LLC
Epilepsy
Effects of Eslicarbazepine Acetate (BIA 2-093) on Cognition and Psychomotor Function
Single-blind, single-centre, fixed-order study to evaluate the PD effects of a single oral dose and multiple oral doses of ESL (BIA 2-093) in healthy volunteers.
- Trial name
- NCT02284828
- Testing
- BIA 2-093
- Volunteers
- 26 people, healthy volunteers welcome
- Sponsor
- Bial - Portela C S.A.